A novel AMPK activator shows therapeutic potential in hepatocellular carcinoma by suppressing HIF1alpha-mediated aerobic glycolysis.

Tseng HI, Zeng YS, Lin YJ, Huang JW, Lin CL, Lee MH, Yang FW, Fang TP, Mar AC, Su JC
Mol Oncol. 2022 Jun;16(11):2274-2294. doi: 10.1002/1878-0261.13211. Epub 2022 Apr 12. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.